Diamond Capital Management

investment firm

About

Diamond Capital Management is dedicated to offering clients well managed alternative investment products that offer consistent returns.

Details

Industries
Finance
Founded date
Jan 1, 2002
Operating Status
Active
Investor Type
PE

Diamond Capital Management is dedicated to offering clients well managed alternative investment products that offer consistent returns and protection of principal achieved through the proper application of money management and continuous evaluation of risk exposure. The principals at Diamond Capital have a solid understanding of the markets and the instruments utilized in the strategies. Past experience has demonstrated that using modifications of tried and true concepts such as proper portfolio diversification, diligent adaptation to market volatility, dollar-cost-averaging with judicious profit taking throughout the investment term, among others, hold the most promise.

Our success is measured against other investment benchmarks, as well as peer group and related industry benchmarks. While short-term performance is always difficult to predict, our long-term goal is to provide consistently attractive returns, within reasonable risk parameters.

In doing so, we at Diamond Capital take personal pride in managing accounts with our clients' best interest in mind.

Diamond Capital Management, LLC, ("DCM") is registered with the Commodity Futures Trading Commission ("CFTC") as a Commodity Trading Advisor ("CTA") and is a member of the National Futures Association ("NFA").

We invite you to investigate Diamond's strategies further and discover a non-correlated alternative investment products to compliment your long term investment goals. To learn more about Diamond Capital and the potential value DCM can add to your overall portfolio, please explore our site, or contact us directly.

Past performance is not necessarily a representation of future results. Alternative investments such as managed futures investments are speculative, involve substantial risk, and are not suitable for all investors.

Investments

Number of Investments
Number of Lead Investments
3
1
Diamond Capital Management has made 3 investments. Their most recent investment was on Jun 17, 2010, when CytoPherx raised $11.70M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 17, 2010 CytoPherx
Series B $11.70M Health Care Yes
Mar 1, 2004 TransMolecular
Series C $33.20M Biotechnology
Feb 24, 2004 NeurogesX
Series C $35M Biotechnology

Exits

Diamond Capital Management has had 2 exits. Diamond Capital Management most notable exits include TransMolecular ,   NeurogesX

Date Company Name Exit Type Industry
Mar 4, 2011 TransMolecular M&A Biotechnology Detail
May 2, 2007 NeurogesX IPO Biotechnology Detail